Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Venous Thrombosis

  Free Subscription


Articles published in Thromb Haemost

Retrieve available abstracts of 77 articles:
HTML format



Single Articles


    November 2021
  1. ROTHBERG MB, Hamilton A, Greene MT, Fox J, et al
    Derivation and Validation of a Risk Factor Model to Identify Medical Inpatients at Risk for Venous Thromboembolism.
    Thromb Haemost. 2021 Nov 16. doi: 10.1055/a-1698-6506.
    PubMed     Abstract available


  2. EVENSEN LH, Arnesen CAL, Rosendaal FR, Gabrielsen ME, et al
    The risk of venous thromboembolism attributed to established prothrombotic genotypes.
    Thromb Haemost. 2021 Nov 16. doi: 10.1055/a-1698-6717.
    PubMed     Abstract available


  3. ZHOU C, Yi Q, Ge H, Wei H, et al
    Validation of risk assessment models predicting venous thromboembolism in inpatients with AECOPD: a multicenter cohort study.
    Thromb Haemost. 2021 Nov 10. doi: 10.1055/a-1693-0063.
    PubMed     Abstract available


  4. KHAN F, Rahman A, Tritschler T, Carrier M, et al
    Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis.
    Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728.
    PubMed     Abstract available


    September 2021
  5. SANCHEZ O, Charles-Nelson A, Ageno W, Barco S, et al
    Reduced-dose intravenous thrombolysis for acute intermediate high-risk pulmonary embolism: Rationale and design of the PEITHO-3 trial.
    Thromb Haemost. 2021 Sep 24. doi: 10.1055/a-1653-4699.
    PubMed     Abstract available


  6. SHARMAN MOSER S, Chodick G, Ni YG, Chalothorn D, et al
    The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events.
    Thromb Haemost. 2021 Sep 23. doi: 10.1055/s-0041-1735971.
    PubMed     Abstract available


  7. MAHE I, Agnelli G, Ay C, Bamias A, et al
    Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: the API-CAT Study.
    Thromb Haemost. 2021 Sep 17. doi: 10.1055/a-1647-9896.
    PubMed     Abstract available


  8. AGNELLI G, Munoz A, Franco L, Mahe I, et al
    Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer.
    Thromb Haemost. 2021 Sep 16. doi: 10.1055/s-0041-1735194.
    PubMed     Abstract available


  9. BIKDELI B, Hogan H, Morrison R, Fanikos J, et al
    Extended-Duration Low-intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism: Design of the HI-PRO Trial.
    Thromb Haemost. 2021 Sep 16. doi: 10.1055/a-1646-2244.
    PubMed     Abstract available


    August 2021
  10. GABARIN N, Patterson S, Pai M, Afzaal T, et al
    Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Thromb Haemost. 2021 Aug 12. doi: 10.1055/a-1585-6182.
    PubMed     Abstract available


    July 2021
  11. VALERIO L, Fedeli U, Schievano E, Avossa F, et al
    Decline in overall pulmonary embolism-related mortality and increasing prevalence of cancer-associated events in the Veneto region (Italy), 2008-2019.
    Thromb Haemost. 2021 Jul 12. doi: 10.1055/a-1548-4948.
    PubMed     Abstract available


  12. RIEDL JM, Schwarzenbacher E, Moik F, Horvath L, et al
    Patterns of thromboembolism in patients with advanced pancreatic cancer undergoing 1st-line chemotherapy with FOLFIRINOX or Gemcitabine/nab-paclitaxel.
    Thromb Haemost. 2021 Jul 12. doi: 10.1055/a-1548-4847.
    PubMed     Abstract available


  13. NOUMEGNI SR, Hoffmann C, Tromeur C, Didier R, et al
    Risk Factors of Arterial Events in Patients with Venous Thromboembolism: A Systematic Review and Meta-Analysis.
    Thromb Haemost. 2021 Jul 11. doi: 10.1055/s-0041-1732300.
    PubMed     Abstract available


  14. FRISCHMUTH T, Hindberg K, Aukrust P, Ueland T, et al
    Plasma Levels of Leptin and Risk of Future Incident Venous Thromboembolism.
    Thromb Haemost. 2021 Jul 11. doi: 10.1055/s-0041-1732295.
    PubMed     Abstract available


    June 2021
  15. VAN DE BRUG A, De Winter M, Ten Wolde M, Kaasjager K, et al
    Deciding on treatment duration for unprovoked venous thromboembolism: what is important to patients?
    Thromb Haemost. 2021 Jun 24. doi: 10.1055/a-1535-8726.
    PubMed     Abstract available


  16. BONNESEN K, Schmidt M, Horvath-Puho E, Sorensen HT, et al
    The interaction effect between comorbidity and venous thromboembolism on mortality rates after venous thromboembolism: A 5-year cohort study.
    Thromb Haemost. 2021 Jun 11. doi: 10.1055/a-1527-6215.
    PubMed     Abstract available


  17. MORA D, Nieto JA, Mateo J, Bikdeli B, et al
    Machine learning to predict outcomes in patients with acute pulmonary embolism who prematurely discontinued anticoagulant therapy.
    Thromb Haemost. 2021 Jun 9. doi: 10.1055/a-1525-7220.
    PubMed     Abstract available


    May 2021
  18. HENDRIKS S, Bistervels I, Eijsvogel M, Faber L, et al
    Home treatment compared to initial hospitalization in patients with acute pulmonary embolism in the Netherlands: a cost analysis.
    Thromb Haemost. 2021 May 26. doi: 10.1055/a-1518-1847.
    PubMed     Abstract available


  19. FRISCHMUTH T, Hindberg K, Gabrielsen ME, Brumpton BM, et al
    Joint effect of multiple prothrombotic genotypes and obesity on the risk of incident venous thromboembolism.
    Thromb Haemost. 2021 May 3. doi: 10.1055/a-1497-9777.
    PubMed     Abstract available


    April 2021
  20. FREI AN, Stalder O, Limacher A, Mean M, et al
    Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism.
    Thromb Haemost. 2021 Apr 30. doi: 10.1055/s-0041-1726345.
    PubMed     Abstract available


  21. PASTORI D, Agnelli G
    Risk Scores for Death in Patients with Cancer-related Venous Thromboembolism: Still a Long Road Ahead.
    Thromb Haemost. 2021 Apr 22. doi: 10.1055/s-0041-1727244.
    PubMed    


  22. GIRARD P, Laporte S, Chapelle C, Falvo N, et al
    Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study.
    Thromb Haemost. 2021 Apr 20. doi: 10.1055/a-1486-7497.
    PubMed     Abstract available


  23. MOOR J, Baumgartner C, Mean M, Stalder O, et al
    Validation of the 2019 European Society of Cardiology risk stratification algorithm for pulmonary embolism in normotensive elderly patients.
    Thromb Haemost. 2021 Apr 6. doi: 10.1055/a-1475-2263.
    PubMed     Abstract available


    February 2021
  24. HOSKIN S, Brieger D, Chow V, Kritharides L, et al
    Trends in Acute Pulmonary Embolism Admission Rates and Mortality Outcomes in Australia, 2002-2003 to 2017-2018: A Retrospective Cohort Study.
    Thromb Haemost. 2021 Feb 28. doi: 10.1055/s-0041-1725932.
    PubMed     Abstract available


  25. HERRERA-RIVERO M, Stoll M, Hegenbarth JC, Ruhle F, et al
    Single- and Multimarker Genome-Wide Scans Evidence Novel Genetic Risk Modifiers for Venous Thromboembolism.
    Thromb Haemost. 2021 Feb 16. doi: 10.1055/s-0041-1723988.
    PubMed     Abstract available


  26. KING A, Leider H, Herman D, Malinowski AK, et al
    Patient- and Health-Care-Provider-Reported Outcomes to Consider in Research on Pregnancy-Associated Venous Thromboembolism.
    Thromb Haemost. 2021 Feb 10. doi: 10.1055/s-0041-1722855.
    PubMed     Abstract available


  27. KUCZMIK W, Wysokinski WE, Hesley GK, Vlazny DT, et al
    Calf Vein Thrombosis Comparison of Outcomes for Axial and Muscular Venous Thrombosis.
    Thromb Haemost. 2021;121:216-223.
    PubMed     Abstract available


    January 2021
  28. COHEN SL, Gianos E, Barish MA, Chatterjee S, et al
    Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients.
    Thromb Haemost. 2021 Jan 20. doi: 10.1055/a-1366-9656.
    PubMed     Abstract available


  29. LI XQ, Hu YH, Lin P, Zhang JR, et al
    Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer.
    Thromb Haemost. 2021 Jan 15. doi: 10.1055/a-1355-3549.
    PubMed     Abstract available


  30. ORIONE C, Tromeur C, Le Mao R, Le Floch PY, et al
    The Impact of Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: A French Prospective Cohort.
    Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1722190.
    PubMed     Abstract available


  31. WENDELBOE AM, Campbell J, Ding K, Bratzler DW, et al
    Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma.
    Thromb Haemost. 2021 Jan 10. doi: 10.1055/s-0040-1722189.
    PubMed     Abstract available


    December 2020
  32. LE MAO R, Jimenez D, Bikdeli B, Porres-Aguilar M, et al
    Prognostic Impact of Obstructive Sleep Apnea in Patients Presenting with Acute Symptomatic Pulmonary Embolism.
    Thromb Haemost. 2020 Dec 30. doi: 10.1055/s-0040-1721506.
    PubMed     Abstract available


  33. ELIAS A, Aronson D
    Risk of Acute Kidney Injury after Intravenous Contrast Media Administration in Patients with Suspected Pulmonary Embolism: A Propensity-Matched Study.
    Thromb Haemost. 2020 Dec 10. doi: 10.1055/s-0040-1721387.
    PubMed     Abstract available


  34. PROIETTI M, Rivera-Caravaca JM, Esteve-Pastor MA, Marin F, et al
    Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.
    Thromb Haemost. 2020 Dec 9. doi: 10.1055/a-1333-4448.
    PubMed     Abstract available


    November 2020
  35. ZOLLER BA, Svensson P, Huang W, Ji J, et al
    Reactome pathway analysis of venous thromboembolism, peripheral artery disease, stroke, and coronary artery.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/a-1315-2307.
    PubMed     Abstract available


  36. SPIRK D, Sebastian T, Barco S, Banyai M, et al
    Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Thromb Haemost. 2020 Nov 17. doi: 10.1055/s-0040-1720977.
    PubMed     Abstract available


  37. AGENO W, Vedovati MC, Cohen A, Huisman M, et al
    Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study.
    Thromb Haemost. 2020 Nov 17. doi: 10.1055/s-0040-1720975.
    PubMed     Abstract available


  38. ZABCZYK M, Natorska J, Janion-Sadowska A, Metzgier-Gumiela A, et al
    Loose Fibrin Clot Structure and Increased Susceptibility to Lysis Characterize Patients with Central Acute Pulmonary Embolism: The Impact of Isolated Embolism.
    Thromb Haemost. 2020 Nov 13. doi: 10.1055/s-0040-1718762.
    PubMed     Abstract available


  39. COHEN A, Keshishian A, Lee T, Wygant G, et al
    Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis.
    Thromb Haemost. 2020 Nov 10. doi: 10.1055/s-0040-1718728.
    PubMed     Abstract available


    October 2020
  40. SCHULMAN S, Hu Y, Konstantinides S
    Venous Thromboembolism in COVID-19.
    Thromb Haemost. 2020 Oct 24. doi: 10.1055/s-0040-1718532.
    PubMed     Abstract available


    September 2020
  41. PICKER N, Lee AY, Cohen AT, Maraveyas A, et al
    Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study).
    Thromb Haemost. 2020 Sep 2. doi: 10.1055/s-0040-1714739.
    PubMed     Abstract available


    August 2020
  42. XIN L, Sun S, Wang J, Lu W, et al
    Dipeptidyl Peptidase 4 Inhibitors and Venous Thromboembolism Risk in Patients with Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials.
    Thromb Haemost. 2020 Aug 9. doi: 10.1055/s-0040-1715444.
    PubMed    


    July 2020
  43. ELGENDY IY, Fogerty A, Blanco-Molina A, Rosa V, et al
    Clinical Characteristics and Outcomes of Women Presenting with Venous Thromboembolism during Pregnancy and Postpartum Period: Findings from the RIETE Registry.
    Thromb Haemost. 2020 Jul 27. doi: 10.1055/s-0040-1714211.
    PubMed     Abstract available


  44. LEE JK, Chen WH, Lin YS, Chang CH, et al
    Comparison of Effectiveness between Anticoagulation and Thrombolysis Therapy for Pulmonary Embolism in Patients Complicated with Shock: A Nationwide Population-Based Study.
    Thromb Haemost. 2020 Jul 17. doi: 10.1055/s-0040-1713095.
    PubMed     Abstract available


    June 2020
  45. HENDRIKS SV, den Exter PL, Zondag W, Brouwer R, et al
    Reasons for Hospitalization of Patients with Acute Pulmonary Embolism Based on the Hestia Decision Rule.
    Thromb Haemost. 2020 Jun 28. doi: 10.1055/s-0040-1713170.
    PubMed     Abstract available


  46. WANG D, Fan G, Liu X, Wu S, et al
    Renal Insufficiency and Short-Term Outcomes of Acute Pulmonary Embolism: A Systemic Review and Meta-Analysis.
    Thromb Haemost. 2020 Jun 11. doi: 10.1055/s-0040-1712459.
    PubMed     Abstract available


  47. SCHULMAN S, Konstantinides S, Hu Y, Tang LV, et al
    Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing: Observations on NICE Guideline [NG158].
    Thromb Haemost. 2020 Jun 11. doi: 10.1055/s-0040-1712913.
    PubMed    


  48. SPYROPOULOS AC, Ageno W, Cohen AT, Gibson CM, et al
    Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
    Thromb Haemost. 2020;120:924-936.
    PubMed     Abstract available


  49. BAVALIA R, Middeldorp S, Weisser G, Espinola-Klein C, et al
    Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants.
    Thromb Haemost. 2020;120:899-911.
    PubMed     Abstract available


    May 2020
  50. QUEZADA A, Jimenez D, Bikdeli B, Muriel A, et al
    Outcomes after Vena Cava Filter Use in Patients with Cancer-Associated Venous Thromboembolism and Contraindications to Anticoagulation.
    Thromb Haemost. 2020 May 18. doi: 10.1055/s-0040-1710589.
    PubMed     Abstract available


  51. GIUSTOZZI M, Agnelli G, Del Toro-Cervera J, Klok FA, et al
    Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.
    Thromb Haemost. 2020 May 4. doi: 10.1055/s-0040-1712098.
    PubMed     Abstract available


  52. GIUSTOZZI M, Curcio A, Weijs B, Field TS, et al
    Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer.
    Thromb Haemost. 2020;120:847-856.
    PubMed     Abstract available


  53. BETENSKY M, Mueller MG, Amankwah EK, Goldenberg NA, et al
    In Children with Provoked Venous Thromboembolism, Increasing Plasma Coagulability during the First 3 Months Postdiagnosis is Prognostic of Recurrence.
    Thromb Haemost. 2020;120:823-831.
    PubMed     Abstract available


  54. ALBERTSEN IE, Sogaard M, Goldhaber SZ, Piazza G, et al
    Development of Sex-Stratified Prediction Models for Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study.
    Thromb Haemost. 2020;120:805-814.
    PubMed     Abstract available


  55. XU K, Chan NC
    Refining Risk Prediction for Recurrent Venous Thromboembolism: Can We Do Better?
    Thromb Haemost. 2020;120:725-727.
    PubMed    


    April 2020
  56. CATTANEO M, Bertinato EM, Birocchi S, Brizio C, et al
    Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
    Thromb Haemost. 2020 Apr 29. doi: 10.1055/s-0040-1712097.
    PubMed    


  57. ZHAI Z, Li C, Chen Y, Gerotziafas G, et al
    Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.
    Thromb Haemost. 2020 Apr 21. doi: 10.1055/s-0040-1710019.
    PubMed     Abstract available


  58. BARCO S, Konstantinides SV
    Predicting Venous Thromboembolism in Primary Care.
    Thromb Haemost. 2020;120:531-533.
    PubMed    


  59. ABDULLA A, Davis WM, Ratnaweera N, Szefer E, et al
    A Meta-Analysis of Case Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding in Patients with Cancer.
    Thromb Haemost. 2020;120:702-713.
    PubMed     Abstract available


  60. DENTALI F, Fontanella A, Cohen AT, Simonetti M, et al
    Derivation and Validation of a Prediction Model for Venous Thromboembolism in Primary Care.
    Thromb Haemost. 2020;120:692-701.
    PubMed     Abstract available


  61. MARCHENA PJ, Tzoran I, Brenner B, Martin M, et al
    Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
    Thromb Haemost. 2020;120:620-626.
    PubMed     Abstract available


    February 2020
  62. WEI WT, Liu PP, Lin SM, Peng CC, et al
    Hypothyroidism and the Risk of Venous Thromboembolism: A Nationwide Cohort Study.
    Thromb Haemost. 2020 Feb 6. doi: 10.1055/s-0039-3402761.
    PubMed     Abstract available


  63. KOOPMANS RJ, Cannegieter SC, Koot RW, Vleggeert-Lankamp CLA, et al
    Nadroparin Plus Compression Stockings versus Nadroparin Alone for Prevention of Venous Thromboembolism in Cerebellopontine Angle Tumour Excisions: A Cohort Study.
    Thromb Haemost. 2020 Feb 6. doi: 10.1055/s-0039-3402732.
    PubMed     Abstract available


    January 2020
  64. WEYCKER D, Li X, Wygant GD, Lee T, et al
    Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice.
    Thromb Haemost. 2020 Jan 27. doi: 10.1055/s-0039-3400530.
    PubMed    


  65. HARENBERG J, Verhamme P
    The Dangerous Liaisons between Chronic Obstructive Pulmonary Disease and Venous Thromboembolism.
    Thromb Haemost. 2020 Jan 23. doi: 10.1055/s-0039-1701012.
    PubMed    


  66. WALDEN K, Jeppsson A, Nasic S, Karlsson M, et al
    Fibrinogen Concentrate to Cardiac Surgery Patients with Ongoing Bleeding does not Increase the Risk of Thromboembolic Complications or Death.
    Thromb Haemost. 2020 Jan 15. doi: 10.1055/s-0039-3402759.
    PubMed     Abstract available


  67. AL-ANI F, Wang YP, Lazo-Langner A
    Development of a Clinical Prediction Rule for Venous Thromboembolism in Patients with Acute Leukemia.
    Thromb Haemost. 2020 Jan 1. doi: 10.1055/s-0039-3400303.
    PubMed     Abstract available


    December 2019
  68. BORVIK T, Braekkan SK, Evensen LH, Brodin EE, et al
    Chronic Obstructive Pulmonary Disease and Risk of Mortality in Patients with Venous Thromboembolism-The Tromso Study.
    Thromb Haemost. 2019 Dec 30. doi: 10.1055/s-0039-3400744.
    PubMed     Abstract available


  69. SCHINDEWOLF M, Weitz JI
    Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment.
    Thromb Haemost. 2019 Dec 13. doi: 10.1055/s-0039-3400302.
    PubMed     Abstract available


    November 2019
  70. PELARGOS PE, Dunn IF
    Venous Thromboembolism Prophylaxis: Safe, but Still Provocative?
    Thromb Haemost. 2019;119:1716-1718.
    PubMed    


  71. KHORANA AA
    Modeling Complexity: The Case of Cancer-Related Venous Thromboembolism.
    Thromb Haemost. 2019;119:1713-1715.
    PubMed    


    October 2019
  72. ISAKSEN T, Evensen LH, Braekkan SK, Hansen JB, et al
    Dietary Intake of Marine Polyunsaturated n-3 Fatty Acids and Risk of Recurrent Venous Thromboembolism.
    Thromb Haemost. 2019 Oct 28. doi: 10.1055/s-0039-1697663.
    PubMed     Abstract available


  73. LIN SY, Chang YL, Yeh HC, Lin CL, et al
    Blood Transfusion and Risk of Venous Thromboembolism: A Population-Based Cohort Study.
    Thromb Haemost. 2019 Oct 22. doi: 10.1055/s-0039-1697664.
    PubMed     Abstract available


  74. SQUIZZATO A, Agnelli G, Campanini M, Dentali F, et al
    Prophylaxis of Venous Thromboembolism after Hospital Discharge in Internal Medicine: Findings from the Observational FADOI-NoTEVole Study.
    Thromb Haemost. 2019 Oct 21. doi: 10.1055/s-0039-1697661.
    PubMed     Abstract available


  75. PETERSEN PB, Jorgensen CC, Kehlet H
    Venous Thromboembolism despite Ongoing Prophylaxis after Fast-Track Hip and Knee Arthroplasty: A Prospective Multicenter Study of 34,397 Procedures.
    Thromb Haemost. 2019 Oct 6. doi: 10.1055/s-0039-1696686.
    PubMed     Abstract available


  76. ERICKSON RM, Feehan M, Munger MA, Tak C, et al
    Understanding Factors Associated with Quality of Life in Patients with Venous Thromboembolism.
    Thromb Haemost. 2019 Oct 6. doi: 10.1055/s-0039-1696717.
    PubMed     Abstract available


  77. SCHELLONG SM, Goldhaber SZ, Weitz JI, Ageno W, et al
    Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry.
    Thromb Haemost. 2019;19:1675-1685.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: